165 related articles for article (PubMed ID: 37191308)
21. Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT).
van den Berg K; Schaap DP; Voogt ELK; Buffart TE; Verheul HMW; de Groot JWB; Verhoef C; Melenhorst J; Roodhart JML; de Wilt JHW; van Westreenen HL; Aalbers AGJ; van 't Veer M; Marijnen CAM; Vincent J; Simkens LHJ; Peters NAJB; Berbée M; Werter IM; Snaebjornsson P; Peulen HMU; van Lijnschoten IG; Roef MJ; Nieuwenhuijzen GAP; Bloemen JG; Willems JMWE; Creemers GJM; Nederend J; Rutten HJT; Burger JWA
BMC Cancer; 2022 Sep; 22(1):957. PubMed ID: 36068495
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant treatment intensification or adjuvant chemotherapy for locally advanced carcinoma rectum: The optimum treatment approach remains unresolved.
Mallick S; Benson R; Haresh KP; Rath GK
J Egypt Natl Canc Inst; 2015 Dec; 27(4):179-85. PubMed ID: 26071798
[TBL] [Abstract][Full Text] [Related]
23. Author response: Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.
Wu Q; He Y; Wang Z
Br J Surg; 2024 Jan; 111(1):. PubMed ID: 37995277
[No Abstract] [Full Text] [Related]
24. Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta-analysis.
Chan KKW; Saluja R; Delos Santos K; Lien K; Shah K; Cramarossa G; Zhu X; Wong RKS
Int J Cancer; 2018 Jul; 143(2):430-437. PubMed ID: 29441562
[TBL] [Abstract][Full Text] [Related]
25. [Short-course radiotherapy combined with CAPOX and PD-1 inhibitor for the total neoadjuvant therapy of locally advanced rectal cancer: the preliminary single-center findings of a prospective, multicentre, randomized phase II trial (TORCH)].
Wang YQ; Shen LJ; Wan JF; Zhang H; Wang Y; Wu X; Wang JW; Wang RJ; Sun YQ; Tong T; Huang D; Wang L; Sheng WQ; Zhang X; Cai GX; Xu Y; Cai SJ; Zhang Z; Xia F
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):448-458. PubMed ID: 37217353
[No Abstract] [Full Text] [Related]
26. Current status of neoadjuvant therapy for locally advanced rectal cancer in Wuhan Union Hospital Cancer Center.
Zhai ML; Zhang FY; Yang JR; Zhang S; Zhao L; Lin ZY; Wang J; Yu DD; Zhang T
Radiat Oncol; 2022 Jun; 17(1):109. PubMed ID: 35718789
[TBL] [Abstract][Full Text] [Related]
27. Impact of total neoadjuvant therapy consisting of consolidation chemotherapy on locally advanced rectal cancer survival.
Zhang H; Li G; Cao K; Zhai Z; Wei G; Qu H; Wang Z; Han J
Int J Colorectal Dis; 2022 Jul; 37(7):1657-1668. PubMed ID: 35716183
[TBL] [Abstract][Full Text] [Related]
28. Comment on: Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.
Zhang W; Huang J
Br J Surg; 2024 Jan; 111(1):. PubMed ID: 37995275
[No Abstract] [Full Text] [Related]
29. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
[TBL] [Abstract][Full Text] [Related]
30. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
31. Preoperative short-course radiotherapy followed by consolidation chemotherapy for treatment with locally advanced rectal cancer: a meta-analysis.
Wu H; Fan C; Fang C; Huang L; Li Y; Zhou Z
Radiat Oncol; 2022 Jan; 17(1):14. PubMed ID: 35073940
[TBL] [Abstract][Full Text] [Related]
32. Comparison of short course radiotherapy with chemoradiotherapy for locally advanced rectal cancers in the elderly: A multicentre, randomised, non-blinded, phase 3 trial.
François E; De Bari B; Ronchin P; Nouhaud E; Martel-Lafay I; Artru P; Clavere P; Vendrely V; Boige V; Gargot D; Lemanski C; De Sousa Carvalho N; Gal J; Pernot M; Magné N
Eur J Cancer; 2023 Feb; 180():62-70. PubMed ID: 36535196
[TBL] [Abstract][Full Text] [Related]
33. Preoperative sequential short-course radiation therapy and FOLFOX chemotherapy versus long-course chemoradiotherapy for locally advanced rectal cancer: a multicenter, randomized controlled trial (SOLAR trial).
Kang MK; Park SY; Park JS; Kim HJ; Kim JG; Kang BW; Baek JH; Cho SH; Seo AN; Kim DW; Kim J; Baek SJ; Kim JH; Kim JY; Ha GW; Park EJ; Park IJ; Kim CH; Kang H; Choi GS
BMC Cancer; 2023 Nov; 23(1):1059. PubMed ID: 37923987
[TBL] [Abstract][Full Text] [Related]
34. Oncologic and survival outcomes in elderly patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy and total mesorectal excision.
He F; Chen M; Xiao WW; Zhang Q; Liu Y; Zheng J; Wan XB; Gao YH
Jpn J Clin Oncol; 2021 Aug; 51(9):1391-1399. PubMed ID: 34155513
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy before Surgery for Treating Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis.
Liao CK; Kuo YT; Lin YC; Chern YJ; Hsu YJ; Yu YL; Chiang JM; Hsieh PS; Yeh CY; You JF
Curr Oncol; 2022 May; 29(5):3708-3727. PubMed ID: 35621687
[TBL] [Abstract][Full Text] [Related]
36. Association between neoadjuvant chemoradiation and survival for patients with locally advanced rectal cancer.
Sun Z; Adam MA; Kim J; Turner MC; Fisher DA; Choudhury KR; Czito BG; Migaly J; Mantyh CR
Colorectal Dis; 2017 Dec; 19(12):1058-1066. PubMed ID: 28586509
[TBL] [Abstract][Full Text] [Related]
37. Downstaging in Advanced Rectal Cancers: A Propensity-Matched Comparison Between Short-Course Radiotherapy Followed by Chemotherapy and Long-Course Chemoradiotherapy.
Kammar PS; Garach NR; Masillamany S; de'Souza A; Ostwal V; Saklani AP
Dis Colon Rectum; 2022 Oct; 65(10):1215-1223. PubMed ID: 34907988
[TBL] [Abstract][Full Text] [Related]
38. Pilot study of intense neoadjuvant chemoradiotherapy for locally advanced rectal cancer: retrospective review of a phase II study.
Xu BH; Chi P; Guo JH; Guan GX; Tang TL; Yang YH; Chen MQ; Song JY; Feng CY
Tumori; 2014; 100(2):149-57. PubMed ID: 24852858
[TBL] [Abstract][Full Text] [Related]
39. Prognostic implication of the neoadjuvant rectal score and other biomarkers of clinical outcome in Hong Kong Chinese patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
Ho SSK; Hon SSF; Hung E; Lee JFY; Mo F; Tong M; So C; Chu S; Ng DCK; Lam D; Cho C; Mak TWC; Ng SSM; Futaba K; Suen J; To KF; Chan AWH; Yeung WWK; Ma BBY
Hong Kong Med J; 2022 Jun; 28(3):230-238. PubMed ID: 35667869
[TBL] [Abstract][Full Text] [Related]
40. Total Neoadjuvant Therapy Significantly Increases Complete Clinical Response.
Rettig RL; Beard BW; Ryoo JJ; Kulkarni S; Gulati M; Tam M; Attaluri V
Dis Colon Rectum; 2023 Mar; 66(3):374-382. PubMed ID: 35239525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
